期刊文献+

立体定向适形放疗对肝细胞癌端粒酶活性的抑制作用 被引量:8

Inhibition of stereotactic ally-guided conformal radiotherapy on the telomerase activity in hepatocellular carcinoma
下载PDF
导出
摘要 目的 探讨立体定向适形放疗对原发性肝癌的生物学效应。方法 对16例原发性肝癌病人中6例术前先行立体定向适形放射治疗,1月后再行手术切除,与同期仅行手术切除的另外10例病人进行对比分析,对手术标本进行细胞端粒酶活性检测及DNA电泳分析。结果 立体定向适形放射治疗对原发性肝癌组织有确实的杀伤效应,肿瘤细胞内已无端粒酶活性,DNA电泳显示肿瘤细胞的DNA链呈片状断裂的阶梯状图象。而未行立体定向放疗的10例病人肝癌组织中的端粒酶活性全部阳性,DNA电泳显示其连续完整。结论 立体定向适形放疗对原发性肝癌有强烈的杀伤效应,其机制为射线对肿瘤细胞的DNA造成损伤,并与其对端粒酶活性的抑制有关。 Objective To study the biological effect of the stereotactic ally-guided conformal radiotherapy (SCRT) on hepatocellular carcinoma. Methods Sixteen patients with hepatocellular carcinoma underwent surgical resection, and 6 of them received SCRT before the resection and the others were operated on directly. The telomerase activity assay and the DNA electrophoresis of the tumor cells were performed in the 2 groups. Results The tumor cells were killed by SCRT and the telomerse activity tests were negative in the treated tumor cells, however, the untreated tumor cells were positive. The DNA electrophoresis showed that the DNA of the treated tumor cells was displayed in ladder shape while that of the untreated tumor cells was DNA displayed in comet-tail shape. Conclusion SCRT can induce apoptosis of the hepatocellular carcinoma by inhibiting the activities of telomerase.
出处 《第一军医大学学报》 CSCD 2000年第4期310-312,共3页 Journal of First Military Medical University
关键词 立体定向适形放疗 端粒酶 肝细胞癌 细胞凋亡 liver neoplasms stereotactic conformal radiotherapy telomerase apoptosis
  • 相关文献

参考文献3

  • 1[1] Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of telomeras activity with immortal cells and cancer[J]. Science, 1994, 266:2011.
  • 2[2] Kojima H, Yokosuka O, Imazeki F, et al. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease[J]. Gastroenterology, 1997, 112(2):493-500.
  • 3[3] Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis[J]. Trends Biochem Sci, 1996, 21(10):387-91.

同被引文献42

  • 1胡建林,杨和平.气道支架治疗的进展[J].第三军医大学学报,2004,26(11):1019-1021. 被引量:12
  • 2董永华,林贵.大鼠肝癌肝动脉碘油柱塞后的门脉血供[J].中华放射学杂志,1994,28(9):582-584. 被引量:34
  • 3范卫君,吴沛宏,张亮,黄金华,张福君,顾仰葵,赵明,黄祥龙,郭昌宇.Ⅲ、Ⅳ型肝门区胆管腺癌的介入治疗[J].中华放射学杂志,2005,39(9):925-929. 被引量:17
  • 4胡冰,周岱云,龚彪,钱光相,陈汉,吴孟超.经内镜胆管引流术在肝门部恶性胆管梗阻中的应用及其评价[J].中华外科杂志,1997,35(2):73-76. 被引量:21
  • 5汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社,1996.132.
  • 6Ogura Y. kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence[ J]. Br J Surg, 1998,8591 ) :20.
  • 7Parc Y, Frileux P, Balladur Pet al. Surgical strategy for the management of hilar bile duct cancer[ J]. Br J Surg, 1997 ,84:1675.
  • 8Gerhards MF, van Gulik TM, Bosma A et al. Long - term survival after resection of proximal bile duct carcinoma( Klatskin toumur) [ J]. World J Surg, 1999,23:91.
  • 9Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhepatiac biliary drainage for malignant biliary obstraction [ J ]. Dig Dis Sci, 1999,44 ( 3 ) :542.
  • 10Wagner H J, Knyrim K, Vakil et al. Olastic endoprosthesis versus metal stents in palliative treatment of malignant hilar biliary obstruction: A prospective and randomized trial [ J ]. Endoscopy, 1993,25:213.

引证文献8

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部